Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Entrada Therapeutics Inc (TRDA)

Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Entrada Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors GlobeNewswire - Tue Jun 3, 6:00AM CDT

TRDA : 7.59 (-3.31%)
BIIB : 130.65 (-1.25%)
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Mon Jun 2, 3:30PM CDT

TRDA : 7.59 (-3.31%)
Entrada Therapeutics Receives Authorization in the European Union to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in Patients Living with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping GlobeNewswire - Wed May 28, 6:00AM CDT

TRDA : 7.59 (-3.31%)
Entrada Therapeutics Reports First Quarter 2025 Financial Results GlobeNewswire - Thu May 8, 6:00AM CDT

TRDA : 7.59 (-3.31%)
Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in People Living with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping GlobeNewswire - Mon Mar 24, 6:00AM CDT

TRDA : 7.59 (-3.31%)
Entrada Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results GlobeNewswire - Thu Feb 27, 6:00AM CST

TRDA : 7.59 (-3.31%)
Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44 GlobeNewswire - Mon Feb 24, 6:00AM CST

TRDA : 7.59 (-3.31%)
Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-44-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-44 in Patients Living with Duchenne Muscular Dystrophy GlobeNewswire - Mon Feb 3, 6:00AM CST

TRDA : 7.59 (-3.31%)
Best Momentum Stocks to Buy for December 30th
Best Momentum Stocks to Buy for December 30th Zacks Investment Research - Mon Dec 30, 2024

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 30th:CoreCard Corporation CCRD: This technology solutions and processing services company...

NRXP : 3.44 (unch)
TRDA : 7.59 (-3.31%)
CCRD : 28.30 (-4.17%)
New Strong Buy Stocks for December 30th
New Strong Buy Stocks for December 30th Zacks Investment Research - Mon Dec 30, 2024

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:CoreCard Corporation CCRD: This technology solutions and processing services company has seen the Zacks Consensus Estimate for its...

APPN : 29.46 (-3.69%)
USNA : 29.55 (-0.77%)
NRXP : 3.44 (unch)
TRDA : 7.59 (-3.31%)
CCRD : 28.30 (-4.17%)

Barchart Exclusives

When Expensive Isn’t A Ripoff: Why Some High-Priced Stocks Keep Soaring Barchart - Sun Jun 15, 3:07PM CDT
Some stocks look expensive—until you realize the market still hasn’t priced in how far they can go Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot